Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
about
Biomarkers in dementia: clinical utility and new directionsBrain PET in the diagnosis of Alzheimer's diseaseThe role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2Neuroimaging biomarkers of neurodegenerative diseases and dementiaMultimodality imaging of Alzheimer disease and other neurodegenerative dementiasImaging in Dementia With Lewy Bodies: An Overview.A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysisBiological markers for early detection and pharmacological treatment of Alzheimer's disease.Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stagesMotion discrimination in dementia with Lewy bodies and Alzheimer diseaseBringing functional brain image analysis to the clinician: initial assessment of an online interactive diagnostic aideMultivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosisTreatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.Multimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.Biomarkers in dementia with Lewy bodies: a review.Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy BodiesDifferential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study.Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study.Visuoperceptual assessments for differentiating dementia with Lewy bodies and Alzheimer's disease: illusory contours and other neuropsychological examinations.[18 FDG PET imaging of the brain in the analysis of a dementia syndrome].Neuroimaging in Dementia.Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
P2860
Q27007086-8B82AE8D-A185-4782-9FA7-518F127A4D61Q27011549-43C203D3-C22B-4320-B4B8-79FEAA00072DQ27011665-319A4920-99D2-43D6-9070-DF19E6A56FADQ27691820-017F5CFB-E23E-46D8-B5ED-77B4B797237CQ30870819-339BBA4D-770A-464C-A5E8-8965ED18CE1CQ31120307-358F617D-23A8-425B-82ED-78FF7E17A297Q35158547-BFEB0F0B-6F63-4D1C-BFEE-8909AE472DD7Q35237100-0429E86D-FBF2-4F15-80C8-4D8707A0C7A0Q36073079-DA15466A-822F-47A8-A291-6F39302907A5Q36225137-06DE77B4-F28F-4620-877A-0BB8FB1A128FQ36537633-AA5BBBF8-2677-453E-9D03-1FA29C7C5968Q36745127-B5B6AB24-15BA-4088-B160-1407100DED0AQ36772321-9B77BBB1-36FA-48A5-B83F-EE8CCB740089Q36899995-9722A2E6-39DA-447E-83CA-C9610EA03836Q36944895-F25375B5-9C3C-49AC-A5D5-9EC340D89F8AQ37329050-40984F66-C6FE-4F33-B9FF-B02F36B835AFQ37896548-0A982E5B-D971-454A-9353-843AFAF7E8EEQ38006466-D5544935-7F4D-4BDF-9F85-61E014EC930AQ41650341-72CD5A49-BB7B-4245-AEC3-3F6517238BFCQ41992831-CFDA6E7F-02A7-4E84-9B4F-7452DC2515FFQ43030811-243C88D3-2F5D-4ED0-B2ED-44093231E3DCQ44263262-79FF0C61-4C3D-48C1-8C5D-5FAB2357D922Q44790322-5EB51940-62E1-40A2-88BE-416163F987C7Q48189574-E1DB6E8B-ECF9-4677-8752-01792C7BD9ACQ50588579-1ECA0B44-5C42-486B-91DE-52152C2A5EBBQ50927803-9533D00A-77AB-437C-9BB1-966EE169AC6AQ51800676-6BD74A9A-158A-4685-9B49-A5F6611E6973Q53065605-13E6743E-80AD-49C5-9D68-D10E94FFF512
P2860
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@en
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@nl
type
label
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@en
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@nl
prefLabel
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@en
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@nl
P2093
P921
P1476
Differentiation of Alzheimer's ...... nd neuropsychological testing.
@en
P2093
Bruno Giordani
Carol Persad
Hyonggin An
Kris Wernette
Larry Junck
Mary Heumann
Robert A Koeppe
Roderick Little
Sid Gilman
P304
P356
10.1016/J.EXPNEUROL.2004.06.017
P407
P478
191 Suppl 1
P577
2005-02-01T00:00:00Z